Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 20, 2022

SELL
$87.2 - $114.05 $235,440 - $307,935
-2,700 Closed
0 $0
Q4 2021

Jan 19, 2022

SELL
$119.57 - $139.07 $227,422 - $264,511
-1,902 Reduced 41.33%
2,700 $346,000
Q3 2021

Oct 05, 2021

BUY
$109.17 - $142.35 $3,275 - $4,270
30 Added 0.66%
4,602 $612,000
Q2 2021

Jul 12, 2021

SELL
$100.34 - $115.69 $100,841 - $116,268
-1,005 Reduced 18.02%
4,572 $494,000
Q1 2021

Apr 22, 2021

SELL
$101.51 - $125.27 $44,867 - $55,369
-442 Reduced 7.34%
5,577 $587,000
Q4 2020

Jan 25, 2021

BUY
$85.88 - $105.36 $67,244 - $82,496
783 Added 14.95%
6,019 $626,000
Q3 2020

Oct 16, 2020

BUY
$72.74 - $92.5 $119,875 - $152,440
1,648 Added 45.93%
5,236 $449,000
Q2 2020

Jul 08, 2020

BUY
$48.02 - $79.04 $172,295 - $283,595
3,588 New
3,588 $263,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Ibm Retirement Fund Portfolio

Follow Ibm Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ibm Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on Ibm Retirement Fund with notifications on news.